Key terms

About INSP

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest INSP news

Mar 22 7:40am ET Analysts Offer Insights on Healthcare Companies: Bruker (BRKR), Inspire Medical Systems (INSP) and Pfizer (PFE) Mar 22 5:18am ET Wells Fargo Releases a Hold Rating on Inspire Medical Systems (INSP) Mar 21 2:20am ET Leerink Partners Remains a Hold on Inspire Medical Systems (INSP) Mar 20 5:11pm ET Analysts Conflicted on These Healthcare Names: Inspire Medical Systems (INSP), ACELYRIN, INC. (SLRN) and Vera Therapeutics (VERA) Mar 20 2:38pm ET LivaNova jumps nearly 12% after saying trial likely to meet primary endpoint Mar 19 9:53am ET Snowflake, MongoDB downgraded to Sell: Wall Street’s top analyst calls Mar 19 8:05am ET Truist Financial Gives a Buy Rating to Inspire Medical Systems (INSP) Mar 19 5:54am ET Inspire Medical initiated with an Overweight at Morgan Stanley Mar 04 9:10am ET Inspire Medical growth intact despite GLP-1 fears, says UBS Feb 27 5:21pm ET Inspire Medical reports Q3 adjusted EPS 17c vs. 41c last year Feb 13 6:02am ET ‘Fundamentals Appear Positive’: KeyBanc Suggests 2 MedTech Stocks With up to ~40% Upside Feb 13 5:09am ET Inspire Medical Systems: Holding Position Amidst Regulatory Challenges and Market Shifts Feb 11 1:01am ET Inspire Medical’s New Regulation Risk – A Cause for Worry? Feb 07 9:06am ET Inspire Medical price target raised to $280 from $265 at Truist Feb 07 8:54am ET Inspire Medical price target raised to $270 from $240 at Lake Street Feb 07 8:41am ET Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Qiagen (QGEN) and Inspire Medical Systems (INSP) Feb 07 8:30am ET Inspire Medical price target raised to $265 from $230 at BofA Feb 07 8:27am ET Inspire Medical Systems: A Hold Rating Amidst Short-Term Uncertainty and Competitive Pressures Feb 07 7:19am ET Lost Money in MBLY, BNTX, DADA, INSP or ON? Class Action Suits Filed, Seeking Recovery Feb 07 7:13am ET Inspire Medical price target raised to $265 from $220 at UBS Feb 07 7:10am ET Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Inspire Medical Systems (INSP) and Gilead Sciences (GILD) Feb 07 6:54am ET Inspire Medical price target raised to $273 from $242 at Baird Feb 07 6:53am ET Inspire Medical price target raised to $250 from $225 at Mizuho Feb 07 5:31am ET Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), GE Healthcare Technologies Inc (GEHC) and Inspire Medical Systems (INSP) Feb 07 4:39am ET Inspire Medical Systems Engages Investors with Upcoming Meetings Feb 06 4:14pm ET Inspire Medical shares jump over 3% after Q4 results surpass estimates Feb 06 4:09pm ET Inspire Medical backs FY24 revenue view $775M – $785M, consensus $780.26M Feb 06 4:08pm ET Inspire Medical reports Q4 EPS 49c, consensus (10c) Feb 06 9:55am ET Tesla downgraded, UPS upgraded: Wall Street’s top analyst calls Feb 06 8:10am ET Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Astria Therapeutics (ATXS) and Inspire Medical Systems (INSP) Feb 06 4:45am ET Inspire Medical resumed with an Overweight at KeyBanc

No recent news articles are available for INSP

INSP Financials

1-year income & revenue

Key terms

INSP Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

INSP Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms